Mission Statement Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.

Addiction Medicine Review Course & Board Exam Preparation Track

August 24 - 27, 2017 
Hilton Union Square, San Francisco

This Course presents an overview of the core elements of addiction medicine, presented by top experts in the field. It can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the Board of Addiction Exam. Participants sit at tables with a facilitator to guide case discussions. Participants receive a course syllabus on a USB drive with copies of all lecture handouts and selected articles and have the opportunity to purchase a print syllabus. Up to 19 units of AMA/PRA Category 1 Credit. Friday: 7 units; Saturday: 7 units; Sunday: 5 units

CSAM Takes Part in Federal Grant to Expand Medication Assisted Treatment (MAT) in California

The California Society of Addiction Medicine (CSAM) has been selected by the California Department of Health Care Services (DHCS) to be part of a statewide collaborative project that includes UCLA Integrated Substance Abuse Programs, to increase access to addiction treatment, reduce unmet treatment need, and reduce opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD).

CSAM will provide training, education, and mentoring to primary care providers as part of this two-year $90 million federal grant under the 21st Century Cures Act that is targeting healthcare in counties and tribal communities that have the highest rates of opioid-related overdose deaths or where treatment resources are inadequate compared to need. The program is being called the “Medication Assisted Treatment (MAT) Expansion Project” and it is focused on populations with limited MAT access including rural areas, American Indian and Native Alaskan tribal communities, and providing access to buprenorphine, a medication used to treat opioid addiction in the privacy of a physician’s office. One part of this project is the selection of 19 treatment programs in counties across the state to receive targeted funding, support for providers, training and other needed resources. CSAM is supporting this part of the project modeled after Vermont’s “Hub and Spoke” system that dramatically increased access to medication assisted treatment (MAT), reduced stigma, and reduced overdose death rates by increasing access to medications used to treat opioid addiction. Vermont now has the highest per capita capacity for treating Opioid Use Disorder (OUD) in the country.

“CSAM is honored to be a coalition partner in this grant and we support the state’s goal of improving access to care for addiction treatment by increasing the number of people receiving treatment by 20,000 over the next two years,” said Jean Marsters, MD, Chair of CSAM’s Committee on Education. “CSAM will help create a foundation for sustainable treatment programs by providing training and mentorship of healthcare providers by addiction medicine specialists, by working to overcome barriers to care, and by updating guidelines that will inform providers on treatment protocols consistent with current State and Federal regulations,” said Marsters. [read more]

An informational meeting will be held for CSAM members and other interested providers during the CSAM Addiction Medicine Review Course, on Friday, August 25,  7-8 AM at the San Francisco Hilton Union Square, located at 333 O'Farrell Street, San Francisco. To attend, contact CSAM at: csam@csam-asam.org

Continuing Medical Education

CSAM Webinar Series

CSAM is sponsoring a series of 12 monthly webinars designed to support the implementation of Medication Assisted Treatment (MAT) of opioid use disorders in primary care.   

 Friday, June 23, 2017, 12:00 noon PDT
 Complex Chronic Pain, Opioid Prescribing and Opioid Use Disorder: Pitfalls, Pearls and New Directions

Friday, September 22, 2017, 12:00 noon PDT
Transitioning High-Dose Opioid Chronic Pain Patients to Buprenorphin

Friday, Oct. 27, 2017 12:00 noon PDT
Medication Assisted Treatment for Alcohol Use Disorder